Seminars in Radiation Oncology
Volume 20, Issue 1 , Pages 58-66 , January 2010

Brain Tumors Across the Age Spectrum: Biology, Therapy, and Late Effects

  • Thomas E. Merchant, DO, PhD

      Affiliations

    • Division of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, TN
    • Corresponding Author InformationAddress reprint requests to Thomas E. Merchant, DO, PhD, Division of Radiation Oncology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Mail Stop 220, Memphis, TN 38105-3678
    • ,
  • Ian F. Pollack, MD, FACS, FAAP

      Affiliations

    • Department of Pediatric Neurosurgery, Children's Hospital of Pittsburgh, PA
    • Department of Neurological Surgery, University of Pittsburgh, School of Medicine, Pittsburgh, PA
    • ,
  • Jay S. Loeffler, MD

      Affiliations

    • Department of Radiation Oncology, Harvard Medical School and Massachusetts General Hospital, Boston, MA

References 

  1. CBTRUS. Statistical Report: Primary Brain Tumors in the United States, 2000-04. Hinsdale, IL: Central Brain Tumor Registry of the United States; 2008;
  2. Brat DJ, Parisi JE, Kleinschmidt-DeMasters BK. Surgical neuropathology update: A review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition. Arch Pathol Lab Med. 2008;132:993–1007
  3. Fernandez C, Figarella-Branger D, Girard N. Pilocytic astrocytomas in children: prognostic factors—a retrospective study of 80 cases. Neurosurgery. 2003;53:544–553
  4. Merchant TE, Kun LE, Wu S. A phase II trial of conformal radiation therapy for pediatric low-grade glioma. J Clin Oncol. 2009;27:3598–3604
  5. Ellison D, Kocak M, Figarella-Branger D. Histopathological grading of intracranial pediatric ependymomas. Neuro Oncol. 2008;10:407
  6. Merchant TE, Jenkins JJ, Burger PC. Influence of tumor grade on time to progression after irradiation for localized ependymoma in children. Int J Radiat Oncol Biol Phys. 2002;53:52–57
  7. Merchant TE, Li C, Xiong X. Conformal radiotherapy after surgery for paediatric ependymoma: A prospective study. Lancet Oncol. 2009;10:258–266
  8. Packer RJ, Gajjar A, Vezina G. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006;24:4202–4208
  9. Duffner PK, Horowitz ME, Krischer JP. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med. 1993;328:1725–1731
  10. Rutkowski S, Bode U, Deinlein F. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med. 2005;352:978–986
  11. Merchant TE, Kun LE, Krasin MJ. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma. Int J Radiat Oncol Biol Phys. 2008;70:782–787
  12. Ashley D, Merchant TE, Zhou T. P9934: systemic chemotherapy, second look surgery and conformal radiation therapy limited to the posterior fossa and primary site for children >8 months and <3 years with nonmetastatic medulloblastoma (A Children's Oncology Group phase III study). Neuro Oncol. 2008;10:436–437
  13. Lai R. Survival of patients with adult medulloblastoma: A population-based study. Cancer. 2008;112:1568–1574
  14. Chan AW, Tarbell NJ, Black PM. Adult medulloblastoma: Prognostic factors and patterns of relapse. Neurosurgery. 2000;47:623–631
  15. Abacioglu U, Uzel O, Sengoz M. Medulloblastoma in adults: Treatment and prognostic factors. Int J Radiat Oncol Biol Phys. 2002;54:855–860
  16. Brandes AA, Ermani M, Amista P. The treatment of adults with medulloblastoma: A prospective trial. Int J Radiat Oncol Biol Phys. 2003;57:755–761
  17. Pfister S, Remke M, Benner A. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J Clin Oncol. 2009;27:1627–1636
  18. Mendrzyk F, Radlwimmer B, Joos S. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma. J Clin Oncol. 2005;23:8853–8862
  19. Perry A, Miller CR, Gujrati M. Malignant gliomas with primitive neuroectodermal tumor-like components: A clinicopathologic and genetic study of 53 cases. Brain Pathol. 2009;19:81–90
  20. Merchant TE. Three-dimensional conformal radiation therapy for ependymoma. Childs Nerv Syst. 2009;25:1261–1268
  21. Timmermann B, Kortmann RD, Kuhl J. Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: Results of the German prospective trials HIT 88/89 and HIT 91. Int J Radiat Oncol Biol Phys. 2000;46:287–295
  22. Brannon ME, Li C, Khan RB. Evolution of neurological impairment in pediatric infratentorial ependymoma patients. J Neurooncol. 2009;94:391–398
  23. Conklin HM, Li C, Xiong X, et al. Predicting change in academic abilities after conformal radiation therapy for localized ependymoma. J Clin Oncol. 2008;26:3965–3970
  24. Merchant TE, Chitti RM, Li C: Factors associated with neurological recovery of brainstem function following post-operative conformal radiation therapy in infratentorial ependymoma. Int J Radiat Oncol Biol Phys (in press)
  25. Metellus P, Barrie M, Figarella-Branger D. Multicentric French study on adult intracranial ependymomas: Prognostic factors analysis and therapeutic considerations from a cohort of 152 patients. Brain. 2007;130:1338–1349
  26. Ruda R, Gilbert M, Soffietti R. Ependymomas of the adult: Molecular biology and treatment. Curr Opin Neurol. 2008;21:754–761
  27. Metellus P, Barrie M, FigarellaBranger D. Intracranial ependymomas in adult patients: Retrospective analysis of 121 cases from the multicentric French study. Neurochirurgie. 2007;53:66–75
  28. Rogers L, Pueschel J, Spetzler R. Is gross-total resection sufficient treatment for posterior fossa ependymomas?. J Neurosurg. 2005;102:629–636
  29. Mendrzyk F, Korshunov A, Benner A. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma. Clin Cancer Res. 2006;12:2070–2079
  30. Jeuken JW, Sprenger SH, Gilhuis J. Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH. J Pathol. 2002;197:238–244
  31. Broniscer A, Baker SJ, West AN. Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. J Clin Oncol. 2007;25:682–689
  32. Pfister S, Janzarik WG, Remke M. BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest. 2008;118:1739–1749
  33. Forshew T, Tatevossian RG, Lawson AR. Activation of the ERK/MAPK pathway: A signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol. 2009;218:172–181
  34. Cheng Y, Pang JC, Ng HK. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas. Histopathology. 2000;37:437–444
  35. Hambardzumyan D, Amankulor NM, Helmy KY. Modeling adult gliomas using RCAS/t-va technology. Transl Oncol. 2009;2:89–95
  36. Faury D, Nantel A, Dunn SE. Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors. J Clin Oncol. 2007;25:1196–1208
  37. Eckert A, Kloor M, Giersch A. Microsatellite instability in pediatric and adult high-grade gliomas. Brain Pathol. 2007;17:146–150
  38. Watkins JM, Marshall DT, Patel S: High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas. J Neurooncol (in press)
  39. Broniscer A, Chintagumpala M, Fouladi M. Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children. J Neurooncol. 2006;76:313–319
  40. Merchant TE, Conklin HM, Wu S. Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: Prospective evaluation of cognitive, endocrine, and hearing deficits. J Clin Oncol. 2009;27:3691–3697

PII: S1053-4296(09)00066-6

doi: 10.1016/j.semradonc.2009.09.005

Seminars in Radiation Oncology
Volume 20, Issue 1 , Pages 58-66 , January 2010

Article Tools

* Image Usage & Resolution